Безопасен ли candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract при беременности?

Related ingredients

Frequently asked questions

Безопасен ли candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract при беременности?

No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR reproductive contraindications were identified for microbial/yeast ferment extracts of the listed species; peer‑reviewed literature does not indicate teratogenicity or reproductive toxicity for topical use of such ferments. Cosmetic safety databases (CosIng/EWG) commonly list these as ferment extracts without reproduction flags, consistent with CIR precedent that cosmetic ferments are 'safe as used' when appropriately processed.

Безопасен ли candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract при грудном вскармливании?

No evidence from regulatory sources or peer‑reviewed studies suggests systemic reproductive toxicity or secretion into breast milk from topical application of these microbial ferment extracts; no harmonised classifications or SCCS/CIR warnings were found.

Безопасен ли candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract для кожи малыша?

Hazard and mechanism: no infant‑specific reproductive or developmental effects located. Exposure: dermal absorption from topical ferments is expected to be negligible in adults, but per guidance infant exposure scoring is increased by +1 due to higher surface‑area‑to‑weight and immature barrier, so exposure is assigned 1 for 0–3 yr skin even though systemic absorption is still expected to be low. Note: potential for topical sensitization or infection in severely immunocompromised infants is a general consideration but not a reproductive/developmental finding.

Как VeriMom оценивает candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract?

VeriMom оценивает candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.

Какие безопасные альтернативы candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract при беременности?

См. наш список безопасных альтернатив candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract с аналогичной функцией и классификацией без известных рисков.